ACE2 activators for the treatment of COVID 19 patients

J Med Virol. 2020 Oct;92(10):1701-1702. doi: 10.1002/jmv.25992. Epub 2020 Jun 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics
  • Angiotensin-Converting Enzyme 2 / metabolism*
  • COVID-19 Drug Treatment*
  • Drug Repositioning
  • Humans
  • Polymorphism, Genetic

Substances

  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2